Arkolith/Insider Trading/VIR/Form 4

Sato Vicki L

DirectorVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$209K
Net Open-Market Flow
-$209K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)200$9.98$2K1.1M
Mar 2, 2026Sell(S)22K$9.50$207K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-013630) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML